Executive Summary
This intelligence digest covers 28 filings from September 24, 2026, dominated by corporate restructuring events (insolvencies, mergers, and delistings) across US and Indian markets.
A clear theme is the acceleration of capital recycling through SPAC mergers (Black Hawk, Haymaker V, Live Oak VI, UY Scuti) and tender offers (Utah Medical, Ares Strategic, Beacon Topco, Vista Credit, Evanston Multi-Alpha), with aggregate capital deployment exceeding $500 million. The Indian insolvency landscape shows active resolution plan implementation (Rajeswari Infrastructure, Zicom Electronic Security, Jatalia Global Ventures) with significant shareholder dilution and capital restructuring. Delisting activity is elevated, with three Nasdaq delistings (Jasper Therapeutics, Waldencast, KLX Energy) and one voluntary NYSE delisting (Two Harbors Investment) on the same day, signaling potential distress or strategic repositioning. The banking sector shows consolidation momentum with First Bancorp's acquisition of First Carolina Bancshares valued at ~$1,228 per share. Insider activity is notably absent across most filings, with only Utah Medical's insider group owning 7.9% of shares in a tender offer, providing limited management conviction signals. Forward-looking data points to a catalyst-rich October 2026 with multiple shareholder meetings, open offer deadlines, and merger completion timelines.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from September 23, 2026.
Investment Signals (12)
-
Secured $200M standby equity facility and non-redemption agreements covering up to 2.1M shares for Vesicor Therapeutics merger, reducing deal failure risk but at high cost (15% discount on prepaid advances, 7% premium) [BULLISH for deal completion, BEARISH for post-merger dilution]
- Utah Medical Products ↓ (BULLISH)▲
Launched tender offer for 650K shares (20.5% of outstanding) at $75/share, funded from internal resources, with CEO Kevin Cornwell owning 5.9% and likely to participate - strong capital return signal from a company with no debt
- Independence Realty Trust ↓ (NEUTRAL)▲
Filed S-4 for stock-for-stock merger with CSR, with termination date of June 30, 2027 - fixed exchange ratio exposes CSR shareholders to IRT stock price volatility, creating potential arbitrage opportunity if spread widens
-
NCLT-approved resolution plan extinguishes all promoter shares, consolidates public shares 50:1, and issues 10.1M new shares to resolution applicant at 95% ownership - extreme dilution for existing public shareholders [BEARISH for current holders]
- Pasupati Fincap ↓ (NEUTRAL)▲
Open offer at ₹12/share for 26% stake (1.22M shares) with no minimum acceptance condition - tender period Oct 1-15, 2026, offering liquidity at a fixed price
-
Completed $287.5M IPO (including full over-allotment) plus $8M private placement - well-capitalized SPAC with 2-year window to find merger target [BULLISH for SPAC investors]
- Live Oak Acquisition Corp VI ↓ (BULLISH)▲
Priced $200M IPO at $10/unit, trading on Nasdaq under LOVIU - sixth SPAC from Live Oak, strong track record increases probability of quality acquisition
- Beasley Broadcast Group ↓ (BEARISH)▲
Audit Committee fell below Nasdaq minimum of 3 members after director death, triggering non-compliance - cure period extends to Sept 2027, giving time to recruit but governance risk persists
- UY Scuti Acquisition Corp ↓ (BULLISH)▲
Amended merger with Isdera Group, setting company value at $920M and adjusting conversion ratio to 1/5th per right - valuation increase from original deal suggests improved terms for SPAC shareholders
-
Acquiring First Carolina Bancshares at ~$1,228/share in stock-and-cash deal (14.534 shares + $294.94 cash), with tangible equity adjustments - strategic consolidation in community banking, expected close early 2027 [BULLISH for FBNC]
- KLX Energy Services ↓ (BEARISH)▲
Delisted from Nasdaq on Sept 24, 2026 under Rule 12d2-2(a)(2) - likely failure to meet continued listing standards, significant negative signal for equity holders
-
Voluntarily delisted Class A shares and warrants from Nasdaq, effective Sept 24, 2026 - strategic decision to go private or restructure, potential catalyst for bondholders but negative for public equity liquidity [BEARISH for minority holders]
Risk Flags (10)
- Jatalia Global Ventures/Insolvency↓ [HIGH RISK]▼
Under CIRP since July 9, 2026, first board meeting held Sept 24 approved cessation of directors - resolution plan implementation risks, no financial disclosure, monitoring committee oversight
- Venmax Drugs/Insolvency↓ [MEDIUM RISK]▼
NCLT-directed shareholder meetings for merger scheduled Oct 24, 2026 - no financial data disclosed, uncertainty around valuation and creditor treatment
- Zicom Electronic Security/Insolvency↓ [HIGH RISK]▼
NCLT approved resolution plan on Sept 24, 2026 for Advaita Trading - plan details undisclosed, potential for significant haircuts to creditors and equity wipeout
- TPL Plastech/Merger Risk↓ [MEDIUM RISK]▼
Board meeting Sept 29 to approve merger with parent Time Technoplast (74.86% holder) - minority shareholder protection concerns, no valuation disclosed
- Jasper Therapeutics/Delisting↓ [HIGH RISK]▼
Nasdaq delisted redeemable warrants (JSPRW) on Sept 24, 2026 for failing listing requirements - warrants exercisable at $115/share for common stock, now illiquid, potential common stock listing at risk
- Destiny Alternative Fund/Tender Failure↓ [MEDIUM RISK]▼
Tender offer for $3.5M expired April 28 with zero shares tendered - complete lack of shareholder interest signals dissatisfaction with pricing or fund strategy
- Two Harbors Investment/Delisting↓ [MEDIUM RISK]▼
Voluntarily delisted 9.375% Senior Notes due 2030 from NYSE - removing high-yield debt from exchange suggests potential refinancing or credit deterioration
- Beacon Topco/Financing Risk↓ [HIGH RISK]▼
Tender offer for $15M at $6.66/share contingent on securing up to $60M in PIPE/debt financing - execution risk on financing could derail capital return plan
- ▼
Units began separate trading of shares, warrants, and rights on Sept 24 - creates price discovery risk as components trade independently, potential for warrant/right value erosion
- Columbus Acquisition Corp/Meeting Delay↓ [MEDIUM RISK]▼
Reconvened EGM on Sept 28 after prior adjournment - suggests difficulty securing shareholder approval for business combination or extension, potential liquidation risk
Opportunities (10)
- Independence Realty Trust/CSR Merger↓ (OPPORTUNITY)◆
Fixed exchange ratio creates arbitrage opportunity if IRT stock fluctuates before close (deadline June 30, 2027) - monitor spread for potential convergence trades
- Pasupati Fincap/Open Offer↓ (OPPORTUNITY)◆
₹12/share offer for 26% stake, identified date Sept 17 - shareholders can tender at fixed price, potential for premium if market price below offer during Oct 1-15 window
- RGF Capital Markets/Open Offer↓ (OPPORTUNITY)◆
Identified date Sept 28 for 26% stake offer (39M shares) - no price disclosed yet, but large tender (26% of equity) suggests potential premium for liquidity
- First Bancorp/First Carolina Acquisition↓ (OPPORTUNITY)◆
Stock-and-cash deal at ~$1,228/share with tangible equity adjustment - FBNC shares may benefit from accretion if cost synergies realized, expected close early 2027
- UY Scuti Acquisition Corp/Isdera Merger↓ (OPPORTUNITY)◆
Company value set at $920M with amended conversion terms - SPAC shareholders get 1/5th share per right, potential upside if Isdera valuation justified by fundamentals
- Haymaker Acquisition Corp V/SPAC IPO↓ (OPPORTUNITY)◆
$287.5M trust with 2-year deal window - experienced sponsor (Haymaker) has successful track record, units trading near trust value provide downside protection with upside optionality
- Live Oak Acquisition Corp VI/SPAC IPO↓ (OPPORTUNITY)◆
$200M trust, sixth SPAC from Live Oak with strong M&A track record - units include warrant component (1/2 warrant per unit), potential for significant returns if quality target acquired
- Evanston Multi-Alpha Fund/Tender Offer↓ (OPPORTUNITY)◆
Repurchasing 15% of net assets ($15.7M) at Dec 31 NAV - shareholders can exit at NAV with 3% early charge only if held <1 year, provides liquidity for closed-end fund investors
- Vista Credit Strategic Lending/Tender Offer↓ (OPPORTUNITY)◆
Repurchasing 5% of shares at Sept 30 NAV, no insiders tendering - signals management sees no conflict, provides partial liquidity for non-traded BDC shares
- Ares Strategic Income Fund/Tender Result↓ (OPPORTUNITY)◆
Pro-rata acceptance of 38.2% due to oversubscription (13.1% tendered vs 5% accepted) - strong shareholder demand for liquidity, potential for secondary market premium if NAV stable
Sector Themes (6)
- SPAC Financing Surge◆
Three SPAC IPOs (Haymaker V $287.5M, Live Oak VI $200M) and two SPAC merger financings (Black Hawk $200M SEPA, UY Scuti $920M valuation) on same day - aggregate $1.6B in SPAC activity signals renewed market appetite for blank-check vehicles despite regulatory headwinds
- Indian Insolvency Resolution Wave◆
Four Indian companies (Jatalia Global, Venmax Drugs, Rajeswari Infrastructure, Zicom Electronic) in active CIRP or resolution plan implementation - NCLT-driven restructuring creating extreme dilution for existing shareholders (Rajeswari: 95% to resolution applicant) but potential value for distressed debt investors
- Delisting Acceleration◆
Three Nasdaq delistings (Jasper Therapeutics warrants, Waldencast voluntary, KLX Energy) and one NYSE delisting (Two Harbors notes) on Sept 24 alone - suggests tightening listing standards and strategic decisions to go private, creating illiquidity risk for equity holders
- Tender Offer Liquidity Events◆
Six tender offers (Utah Medical 20.5%, Ares Strategic 5%, Beacon Topco $15M, Destiny Alternative $3.5M, Evanston Multi-Alpha 15%, Vista Credit 5%) - aggregate $50M+ in capital return, with Utah Medical's 20.5% buyback being most aggressive signal of management confidence
- Banking Consolidation Momentum◆
First Bancorp's acquisition of First Carolina Bancshares follows trend of regional bank M&A - stock-and-cash structure with tangible equity adjustment protects acquirer from balance sheet surprises, expected close early 2027
- Corporate Governance Disruptions◆
Beasley Broadcast Group's audit committee non-compliance after director death highlights succession planning risks for small-cap boards - cure period until Sept 2027 provides buffer but governance discount may persist
Watch List (10)
-
Monitor shareholder vote on Vesicor Therapeutics merger - $200M SEPA and non-redemption agreements reduce risk but costly terms may pressure post-merger stock [Date: TBD]
-
Tender period Oct 1-15 at ₹12/share - watch for market price relative to offer and acceptance levels to gauge shareholder sentiment [Date: Oct 1-15, 2026]
-
Identified date Sept 28 for 26% stake open offer - price disclosure pending, monitor for premium/discount to market [Date: Sept 28, 2026]
- TPL Plastech & Time Technoplast/Board Meeting👁
Merger scheme approval on Sept 29 - watch for valuation details and minority shareholder protections [Date: Sept 29, 2026]
-
Reconvened meeting Sept 28 - outcome critical for SPAC survival or liquidation [Date: Sept 28, 2026]
-
NCLT-directed meeting Oct 24 for merger approval - monitor for creditor opposition or valuation challenges [Date: Oct 24, 2026]
-
Delisted from Nasdaq - watch for OTC trading and potential bankruptcy filing if unable to meet debt obligations [Date: Ongoing]
-
Voluntary Nasdaq delisting - monitor for going-private transaction, restructuring, or asset sales [Date: Ongoing]
-
Expected close early 2027 - watch for regulatory approvals and tangible equity adjustments affecting final consideration [Date: Early 2027]
-
Must add independent director by Sept 2027 - monitor recruitment progress and potential governance improvements [Date: By Sept 19, 2027]
Filing Analyses
(28)
24-09-2026
Black Hawk Acquisition Corp (BKHA) entered into a series of financing agreements with Meteora Select Trading Opportunities Master, LP in connection with its pending business combination with Vesicor Therapeutics. The agreements include a Forward Purchase Agreement for up to 1,350,000 shares, a Non-Redemption Agreement covering up to 2,124,077 shares, a Subscription Agreement, and a Standby Equity Purchase Agreement (SEPA) allowing PubCo to sell up to $200.0 million of common stock over 36 months. While the financing provides significant capital and reduces redemption risk, the SEPA includes a 15% original issue discount on pre-paid advances and a 7% payment premium, representing costly capital, and the Non-Redemption Agreement provides only a best-efforts commitment with no minimum obligation.
- · The Business Combination Agreement was dated April 26, 2025.
- · The Forward Purchase Agreement initial price equals the per-share redemption price; reset price initially $10.00 per share.
- · The Non-Redemption Agreement provides for a payment to Meteora of the final per-share redemption price less $0.75 per Backstop Investor Share.
- · The SEPA has no mandatory minimum utilization amount and no non-usage fee.
- · The maximum amount of each ordinary advance under SEPA generally may not exceed 30% of the average daily traded amount during the 10 consecutive trading days preceding the advance notice.
- · The SEPA is subject to a beneficial ownership limitation initially equal to 4.9%, which Meteora may elect to increase up to 9.9%.
- · The Registration Rights Agreement requires coverage of at least 300% of the maximum number of shares issuable upon conversion of all then-outstanding promissory notes.
- · The convertible promissory note has a 12-month maturity, 0% annual interest (18% during uncured event of default), and a floor price on conversion.
24-09-2026
Jatalia Global Ventures Ltd, which is under a Corporate Insolvency Resolution Process (CIRP) pursuant to an NCLT order dated July 9, 2026, has given prior intimation of its first Board of Directors meeting to be held on September 24, 2026, via video conferencing. The meeting is being convened under the approved Resolution Plan and SEBI LODR regulations. No financial figures or performance metrics are disclosed in this filing.
- · Company is under CIRP vide NCLT New Delhi Bench order dated 09.07.2026 in CP No. IB-263/ND/2023.
- · First Board meeting scheduled on shorter notice for September 24, 2026 at 05:00 PM via video conferencing.
- · Mohd Nazim Khan is the Chairman of the Monitoring Committee, IBBI Reg. No. IBBI/IPA-002/IP-N00076/2017-18/10207.
24-09-2026
Venmax Drugs and Pharmaceuticals Ltd has published newspaper advertisements convening meetings of equity shareholders as directed by the NCLT Hyderabad Bench-II under Sections 230-232 of the Companies Act, 2013, in connection with a proposed merger/arrangement. The meetings are scheduled for October 24, 2026, at 12:30 PM. No financial figures or performance metrics are disclosed in this filing.
- · NCLT order dated September 7, 2026, in CA (CAA) No. 30/230/HDB/2026
- · Advertisements published on September 23, 2026, in Financial Express (English) and Nava Telangana (Telugu, Hyderabad Edition)
- · Shareholder meetings scheduled for Saturday, October 24, 2026, at 12:30 PM
- · Complete merger documents available on company website at https://www.venmaxdrugs.com/amalgamation.html
24-09-2026
Utah Medical Products, Inc. (UTMD) announced an issuer tender offer to repurchase up to 650,000 shares of its common stock at $75.00 per share, representing approximately 20.5% of its 3,173,818 outstanding shares as of September 14, 2026. The offer is funded from the company's own resources and is intended to return capital to shareholders. Directors and executive officers collectively own 7.9% of outstanding shares (including options) and may participate in the offer, but no specific participation commitments are disclosed.
- · Directors and executive officers as a group own 228,195 shares directly (7.1%) and 25,600 options (0.8%), totaling 253,795 shares (7.9%).
- · Kevin L. Cornwell, Chairman and CEO, directly owns 188,472 shares (5.9%).
- · The offer is subject to conditions including minimum tender and regulatory approvals.
- · The tender offer expires on a date not specified in this filing; the Offer to Purchase is dated September 22, 2026.
24-09-2026
Independence Realty Trust, Inc. (IRT) filed an S-4 registration statement on September 23, 2026, in connection with its proposed merger with CSR (CSR). The merger will be effected through a stock-for-stock exchange, with each share of CSR Common Stock converting into newly issued IRT Common Stock at a fixed Exchange Ratio. The transaction is subject to stockholder approvals from both companies, regulatory clearances, and other customary conditions, with a termination date of June 30, 2027. Risks highlighted include potential failure to consummate the merger, diversion of management attention, and the fact that the Exchange Ratio will not be adjusted for changes in market prices, exposing CSR shareholders to market risk on the consideration received.
- · The merger must be consummated by June 30, 2027, or either party may terminate the agreement.
- · Termination fees are payable by CSR or IRT under certain circumstances, such as CSR accepting a superior proposal.
- · IRT has the right to defer closing until lender consents for certain CSR mortgage loans are obtained, but no later than June 30, 2027.
- · The Exchange Ratio may be adjusted for stock splits, reverse stock splits, combinations, subdivisions, reclassifications, and REIT dividends declared before closing, but not for regular distributions or market price changes.
- · CSR shareholder approval requires the affirmative vote of holders of at least a majority of outstanding CSR Common Stock.
- · The filing incorporates by reference IRT's and CSR's Quarterly Reports on Form 10-Q for the period ended June 30, 2026, and Annual Reports on Form 10-K for the year ended December 31, 2025.
24-09-2026
Rajeswari Infrastructure Limited is implementing an NCLT-approved Resolution Plan under the Insolvency and Bankruptcy Code, 2016. The plan involves extinguishing all promoter/promoter group shares, reconstituting public shareholding via a 50:1 consolidation (one new share for every 50 existing shares), and issuing 10,10,116 fresh equity shares of ₹10 each to the Resolution Applicant, Mr. Guruswamy Ramamurthy. Post-restructuring, the Resolution Applicant will hold up to 95% of the equity, while public shareholders will hold at least 5%.
- · Record date for capital restructuring is Thursday, 01 October 2026.
- · Promoter and promoter group shares will be extinguished without any payment.
- · Public shares will first be reduced from face value ₹10 to ₹0.20, then consolidated back to ₹10 face value.
- · Fractional entitlements from consolidation will be rounded off to the nearest whole integer.
- · The company will coordinate with stock exchange, registrar, depositories for suspension/cancellation of existing shares and listing of new shares.
24-09-2026
Uday Narang (Acquirer) has launched an Open Offer to acquire up to 12,22,000 (Twelve Lakh Twenty Two Thousand) fully paid-up equity shares of Pasupati Fincap Limited, representing 26.00% of the voting share capital, at an offer price of ₹12 per share, payable in cash. The offer is made pursuant to Regulation 4 of the SEBI (SAST) Regulations, 2011, and is not conditional upon any minimum level of acceptance. The tendering period runs from October 1, 2026 to October 15, 2026.
- · The Open Offer is made pursuant to a Share Purchase Agreement dated August 05, 2026.
- · The Identified Date for determining eligible shareholders is September 17, 2026.
- · The offer is not a competing offer and no competing offer has been made.
- · The Acquirer reserves the right to reject tendered shares if required approvals (e.g., RBI) are not submitted.
- · In case of delay in payment of consideration, interest at 10% per annum may be payable under Regulation 18(11) of SEBI (SAST) Regulations.
- · The Draft Letter of Offer was filed with SEBI on August 19, 2026, and comments were received by September 15, 2026.
24-09-2026
The Hon'ble National Company Law Tribunal (NCLT), Mumbai Bench-I, has approved the resolution plan for Zicom Electronic Security Systems Limited under the Insolvency and Bankruptcy Code, 2016. The plan was submitted by Advaita Trading Private Limited, the successful Resolution Applicant. This marks a key milestone in the company's corporate insolvency resolution process.
- · The order was pronounced on September 24, 2026 in IA(IBC)(Plan)/32/MB/2026 in CP(IB) No. 610 of 2021.
- · The company is currently under Corporate Insolvency Resolution Process (CIRP).
- · The resolution professional is Chirag Shah, registered with IBBI (IBBI/IPA-001/IP-P01169/2018-19/11837).
24-09-2026
RGF Capital Markets Limited has proposed an open offer for up to 3,90,06,240 equity shares, representing 26.00% of the company’s voting share capital, from public shareholders. The identified date for determining shareholders eligible to receive the Letter of Offer is Monday, September 28, 2026; the filing does not disclose an offer price or completion outcome.
- · The identified date is Monday, September 28, 2026.
- · The Public Announcement was dated March 10, 2026, the Detailed Public Statement was published on March 17, 2026, and the Draft Letter of Offer was dated March 24, 2026.
- · The Letter of Offer will be sent to shareholders identified as holding shares on the identified date.
- · The disclosure cites Regulation 18(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulations, 2011.
- · Kunvarji Finstock Private Limited is the Manager to the Open Offer and holds SEBI registration number INM000012564.
24-09-2026
TPL Plastech Limited has scheduled a Board Meeting on September 29, 2026, to consider and approve a Scheme of Merger with its parent company, Time Technoplast Limited, which holds a 74.86% stake. The merger will involve TPL Plastech (Transferor Company) merging into Time Technoplast Limited (Transferee Company) under Sections 230-232 of the Companies Act, 2013, subject to regulatory approvals including NCLT and stock exchanges.
- · The Board Meeting is scheduled for September 29, 2026.
- · The merger requires approval from shareholders, stock exchanges, and NCLT.
- · The filing is an intimation under Regulation 29 of SEBI (LODR) Regulations, 2015.
24-09-2026
Time Technoplast Limited announced a board meeting on September 29, 2026, to consider and approve a scheme of merger of its subsidiary TPL Plastech Limited (74.86% stake) into itself, subject to regulatory approvals including NCLT and stock exchanges. The merger is a consolidation move, but no financial details or valuation figures were disclosed in the filing.
- · Board meeting scheduled for September 29, 2026.
- · Merger proposed under Sections 230 to 232 of the Companies Act, 2013.
- · Approvals required from shareholders, stock exchanges, and NCLT.
- · No financial details or valuation figures were provided in the filing.
24-09-2026
Jatalia Global Ventures Ltd, which is under a Corporate Insolvency Resolution Process (CIRP) by NCLT order dated July 9, 2026, held its first Board meeting on September 24, 2026. The Board approved the cessation of erstwhile directors in compliance with the approved resolution plan and appointed Ms. Manshi Gandhi as Company Secretary and Compliance Officer. No financial results or operational performance data were disclosed.
- · The NCLT New Delhi Bench (Court-II) admitted the CIRP petition (CP No. IB-263/ND/2023) on July 9, 2026.
- · Board meeting was held via Video Conferencing, commenced at 05:45 PM and concluded at 05:55 PM on September 24, 2026.
- · Scrip Code on BSE: 519319.
24-09-2026
Jasper Therapeutics, Inc. received a delisting notice from Nasdaq on September 24, 2026, for its Redeemable Warrants (ticker: JSPRW) under SEC Rule 12d2-2(a)(2). The delisting was initiated by Nasdaq, indicating the company failed to meet continued listing requirements, which is a negative regulatory action affecting the company's securities.
- · The delisting applies specifically to the Redeemable Warrants (each ten warrants exercisable for one share of Voting Common Stock at an exercise price of $115.00)
- · The filing was made under SEC Rule 12d2-2(a)(2), which allows Nasdaq to remove a security from listing
- · The delisting became effective on September 24, 2026
- · Jasper Therapeutics was formerly known as Amplitude Healthcare Acquisition Corp (name change date: September 12, 2019)
24-09-2026
Waldencast plc filed Form 25 with the SEC on September 24, 2026, to voluntarily withdraw its Class A ordinary shares and redeemable warrants from listing and registration on the Nasdaq Stock Market. The delisting is effective under SEC Rule 12d2-2(c), which governs voluntary withdrawal. The company's principal executive offices are in London, UK, and the filing was signed by Executive Chairman Felipe Dutra.
- · Commission File Number: 001-40207
- · Address: 81 Fulham Road, London, SW3 6RD, United Kingdom
- · Telephone: +44 (0)20 3196 0264
- · The delisting is voluntary under SEC Rule 240.12d2-2(c).
24-09-2026
Haymaker Acquisition Corp V filed an 8-K disclosing the consummation of its initial public offering (IPO) of 28,750,000 units at $10.00 per unit, generating gross proceeds of $287.5 million. Simultaneously, it completed a private placement of 5,333,333 warrants at $1.50 each, raising an additional $8.0 million, with proceeds placed in trust. No ongoing negative or flat metrics exist as this is a one-time capital raise for a SPAC targeting a future merger.
- · The IPO included full exercise of the underwriters' over-allotment option (3,750,000 units).
- · Each unit consists of one Class A ordinary share ($0.0001 par value) and one-third of one redeemable warrant exercisable at $11.50 per share.
- · Private placement warrants: 4,000,000 sold to sponsor Haymaker Sponsor V LLC and 1,333,333 sold to the underwriters.
- · Trust account maintained by Continental Stock Transfer & Trust Company, holding $287.5 million ($10.00 per unit).
- · Exhibit 99.1 audited balance sheet as of September 18, 2026 filed with this 8-K.
24-09-2026
Live Oak Acquisition Corp. VI, a blank check company, priced its $200 million initial public offering of 20 million units at $10.00 per unit, with units to trade on Nasdaq under 'LOVIU' starting September 23, 2026. The offering is expected to close on September 24, 2026, and the company will seek a merger or acquisition target in any industry. The company has granted underwriters a 45-day option to purchase up to an additional 3 million units to cover over-allotments.
- · Each unit consists of one Class A ordinary share and one-half of one redeemable warrant.
- · Warrants become exercisable 30 days after completion of initial business combination and expire five years after that.
- · Only whole warrants are exercisable; no fractional warrants will be issued.
- · The company is a blank check company formed to effect a merger or similar business combination with one or more businesses.
- · The company may pursue an acquisition opportunity in any business or industry.
- · Santander is the sole underwriter for the offering.
- · The registration statement became effective on September 22, 2026.
24-09-2026
Beasley Broadcast Group disclosed the passing of independent director Peter A. Bordes, Jr. on September 19, 2026, which reduced its Audit Committee to two members and triggered non-compliance with Nasdaq Rule 5605(c)(2)(A) (requiring at least three independent audit committee members). The company notified Nasdaq and intends to rely on the cure period, which expires at the earlier of the next annual meeting or September 19, 2027, to appoint an additional independent director. This is a governance-related regulatory compliance issue, not a financial performance event.
- · Peter A. Bordes, Jr. served as an independent director since November 2016 and was a member of both the Audit and Compensation Committees.
- · The company notified Nasdaq on September 23, 2026 of the non-compliance.
- · Cure period expires at the earlier of the next annual meeting of stockholders or September 19, 2027.
- · The company intends to appoint an independent director to the Audit Committee within the cure period.
24-09-2026
UY Scuti Acquisition Corp. (UYSCU) entered into a First Amendment to its Agreement and Plan of Merger with Isdera Group Limited and related parties, amending key terms of the July 18, 2025 merger agreement. The amendment sets the Company Net Value at $920,000,000 and adjusts the conversion ratio of Purchaser Rights to one-fifth of one Purchaser Class A Ordinary Share each. The amendment also updates the shareholder allocation and closing payment schedules, and restates the company's authorized share capital as $50,000 divided into 100,000,000 ordinary shares of $0.0005 par value, all of which are issued and outstanding.
- · The amendment was executed on September 22, 2026, and filed on September 24, 2026.
- · Purchaser and Merger Sub executed a Joinder Agreement concurrently with the amendment to become parties to the Merger Agreement.
- · The amendment restates the Shareholders Allocation Schedule and Closing Payment Shares Schedule.
- · All issued and outstanding Company Shares are owned legally and of record by the persons set forth on Schedule 5.5(a).
- · No other class of share capital is authorized or issued beyond the ordinary shares.
24-09-2026
Columbus Acquisition Corp (COLAR), a blank check SPAC, filed an 8-K on September 24, 2026, providing additional logistical details for its reconvened Extraordinary General Meeting of Shareholders scheduled for September 28, 2026. The meeting will be held both in person at Loeb & Loeb LLP in New York and virtually via teleconference. No financial results, business combination updates, or period-over-period comparisons were disclosed in this filing.
- · The Extraordinary General Meeting was originally announced and a definitive proxy statement was filed on August 19, 2026.
- · The meeting will be held at 9:00 a.m. Eastern Time on September 28, 2026.
- · In-person location: Loeb & Loeb LLP, 345 Park Avenue, New York, NY 10154.
- · Virtual dial-in: US/Canada toll-free 1-800-450-7155; international +1-857-999-9155; conference ID 5870682#.
- · The company is a blank check company (SPAC) formed for the purpose of effecting a merger or similar business combination.
- · The company is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.
24-09-2026
Ares Strategic Income Fund filed Amendment No. 1 to its tender offer statement, reporting preliminary results. The Fund received tenders for 50,400,325 Shares (13.1% of outstanding shares as of July 31, 2026), but will only repurchase 5% of outstanding shares, resulting in a pro-rata acceptance of approximately 38.2% of requested amounts. The offer expired on September 18, 2026, and the repurchase price will be the net asset value per share as of August 31, 2026.
- · The tender offer expired at 4:00 p.m. Eastern Time on September 18, 2026.
- · The Fund will accept shares on a pro-rata basis, with odd lot priority for holders of fewer than 100 Shares.
- · No repurchase priority is given for death or disability of a shareholder.
- · The repurchase price is based on net asset value per share as of August 31, 2026 (the Valuation Date).
- · Exhibits added include a Q3 Tender Offer Update and Tender Offer Frequently Asked Questions.
24-09-2026
ARC Group Securities Acquisition I announced that, on or about September 24, 2026, holders of its units may elect to separately trade the underlying Class A ordinary shares, warrants, and rights. This allows the components of the units to trade independently on Nasdaq under symbols FJDI, FJDIW, and FJDIR, while unseparated units continue trading under FJDIU. The filing is a routine procedural update regarding the separability of securities and does not involve a merger, acquisition, or financial performance data.
- · Separate trading of Class A ordinary shares, warrants, and rights begins on or about September 24, 2026.
- · Each unit consists of one Class A ordinary share, one warrant (exercisable for one share at $11.50), and one right (entitling holder to 1/4th of one share upon business combination).
- · Holders must contact transfer agent Efficiency, INC. to separate units.
- · Unseparated units continue trading under FJDIU; separated shares, warrants, and rights trade under FJDI, FJDIW, and FJDIR respectively.
24-09-2026
Beacon Topco, Inc. filed Amendment No. 1 to its Schedule TO, updating its tender offer to purchase up to $15 million of its common stock at $6.6609 per share. The amendment also discloses that the company and Clywedog are pursuing up to $60 million in PIPE financing, debt, or alternative financings. The tender offer was originally filed on September 15, 2026, and this amendment provides additional information on the financing efforts.
- · The tender offer is for shares of common stock with par value $0.0001 per share.
- · The offer price is $6.6609 per share, net to seller in cash, less any applicable withholding taxes and without interest.
- · The company and Clywedog are working together to pursue commitments for up to $60 million in PIPE financing, debt, or other alternative financings.
- · An investor presentation for the PIPE Financing was included as Exhibit (6)(D) to the Schedule TO.
- · The amendment was signed by William Enright, CEO, on September 23, 2026.
24-09-2026
Destiny Alternative Fund filed a final amendment to its Schedule TO, reporting that its tender offer to purchase up to $3.5 million of its own shares expired on April 28, 2026, with zero shares tendered. The offer, originally announced March 25, 2026, attracted no participation from shareholders, resulting in no purchases by the Fund.
- · Tender offer expired at 11:59 p.m. Eastern Time on April 28, 2026.
- · Net asset value for the offer was calculated as of June 30, 2026.
- · No shareholders validly tendered shares by the expiration deadline.
24-09-2026
KLX Energy Services Holdings, Inc. (KLXE) filed a Form 25-NSE with the SEC on September 24, 2026, notifying the delisting of its securities from the Nasdaq Stock Market LLC. The delisting is effective as of the same date and is based on SEC Rule 17 CFR 240.12d2-2(a)(2), which typically applies when the issuer has failed to meet continued listing standards or has voluntarily withdrawn its listing. This filing marks the formal removal of KLXE's common stock from trading on Nasdaq.
- · The delisting is based on SEC Rule 17 CFR 240.12d2-2(a)(2), which covers failure to meet listing standards or voluntary withdrawal.
- · The filing was submitted by Nasdaq Stock Market LLC on behalf of KLX Energy Services Holdings, Inc.
- · The SEC file number for the company is 001-38609.
- · The company's former name was KLX Energy Services Inc., changed on April 26, 2018.
- · The company's business address is 3040 Post Oak Boulevard, 15th Floor, Houston, TX 77056.
24-09-2026
Evanston Multi-Alpha Fund announced a tender offer to repurchase up to $15,691,061 of its Class A and Class I shares, representing 15% of net assets as of July 31, 2026. The offer runs from September 24, 2026 to October 28, 2026, with a repurchase valuation date of December 31, 2026. Shareholders tendering shares within the first year of purchase will incur a 3.00% early repurchase charge. The fund's aggregate net asset value was $104,607,076 as of July 31, 2026, with per-share NAVs of $8.6261 (Class A) and $9.6262 (Class I).
- · The fund is a closed-end, non-diversified management investment company organized as a Delaware statutory trust.
- · Shares are not traded in any market; transfers are strictly limited.
- · Shareholders may withdraw tenders until 11:59 p.m. Eastern time on October 28, 2026 (Expiration Date).
- · If the fund has not accepted a tender by November 23, 2026 (Acceptance Date), the shareholder retains withdrawal rights.
- · Payment for repurchased shares will generally be made within approximately 35 days after the Repurchase Valuation Date (December 31, 2026).
- · For full redemptions, an initial payment of at least 90% of estimated value will be made within ~35 days after the valuation date, with the balance paid after the annual audit.
- · The management fee payable to XA Investments LLC is deducted from fund assets before effecting repurchases.
- · The fund may cancel, amend, or postpone the offer at any time before the Expiration Date.
24-09-2026
Vista Credit Strategic Lending Corp. announced a self-tender offer to repurchase up to 5.0% of its outstanding shares (approximately 2,569,979.367 shares) at net asset value as of September 30, 2026. The offer expires on October 22, 2026, and is open to all stockholders. Notably, no executive officers, directors, or affiliates intend to tender shares, and the company's shares are not traded on any market.
- · Shares are not traded in any market.
- · The purchase price will be net asset value as of September 30, 2026 (Valuation Date).
- · The offer expires at 11:59 p.m. Eastern Time on October 22, 2026.
- · No executive officer, Director, or affiliate intends to tender shares.
- · The Adviser expects to recommend quarterly tender offers, but the Board may amend, suspend, or terminate the program at any time.
- · Certain stockholders have waived voting rights on shares exceeding 4.99% of outstanding.
- · Vista VCSL Feeder Fund, L.P. must submit a tender request beginning in November 2040 under certain conditions.
- · On July 29, 2026, the Company issued 325,656.392 shares to VHG Capital, L.P. at $19.13 per share for aggregate proceeds of $6,230,021.72.
- · In the past 60 days, the Company issued approximately 28.582 shares to the Adviser, Directors, and executive officers for net proceeds of about $546.29.
24-09-2026
Two Harbors Investment Corp. filed Form 25 with the SEC on September 24, 2026, to voluntarily withdraw its 9.375% Senior Notes due 2030 from listing and registration on the New York Stock Exchange. The delisting is effective as of the filing date, and the company certifies it has complied with all applicable exchange rules and SEC requirements.
- · The delisting is voluntary under 17 CFR 240.12d2-2(c).
- · The company's principal executive offices are at 1601 Utica Avenue South, Suite 900, St. Louis Park, MN 55416.
- · The Commission File Number is 001-34506.
24-09-2026
First Bancorp (FBNC) is acquiring First Carolina Bancshares Corporation in a stock-and-cash merger valued at approximately $1,228.31 per share of First Carolina common stock as of July 13, 2026. Under the agreement, each First Carolina share will be exchanged for 14.5340 shares of First Bancorp common stock plus $294.94 in cash, subject to adjustments based on First Carolina's tangible common equity at closing. The transaction requires approval from two-thirds of First Carolina's outstanding shares and is expected to close by early 2027.
- · The merger agreement was entered into on July 13, 2026.
- · First Carolina will merge into First Bancorp, followed by the merger of Carolina Bank & Trust Co. into First Bank.
- · The cash consideration is subject to adjustment if First Carolina's tangible common equity capital is below $110.0M or above $125.0M (if closing on or before January 1, 2027).
- · If certain Carolina Bank employees do not enter employment agreements, the cash consideration will be reduced by $1.5M divided by the number of outstanding First Carolina shares.
- · First Bancorp is a large accelerated filer and not an emerging growth company.
- · The special meeting of First Carolina shareholders will be held to vote on the merger proposal and an adjournment proposal.
- · Dissenters' rights are available under South Carolina law for shareholders who do not vote in favor.
- · The registration statement is preliminary and subject to completion.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 28 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Global High-Priority Regulatory Events
September 22, 2026
Global High-Priority Regulatory Events — September 22, 2026
September 21, 2026
Global High-Priority Regulatory Events — September 21, 2026
September 17, 2026
Global High-Priority Regulatory Events — September 17, 2026
September 16, 2026
Global High-Priority Regulatory Events — September 16, 2026
🇺🇸 More from United States
View all →September 24, 2026
US Pre-Market SEC Filings Roundup — September 24, 2026
US Pre-Market SEC Filings Roundup
September 24, 2026
USA Corporate Events Calendar — September 24, 2026
USA Corporate Events Calendar
September 24, 2026
USA Earnings Calls Schedule — September 24, 2026
USA Earnings Calls Schedule
September 24, 2026
US SEC Filings Daily Market Digest — September 24, 2026
US SEC Filings Daily Market Digest